Osteoprotegerin and the development of myeloma bone disease

Eitemau Tebyg

• Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
  gan: Croucher, P, et al.
  Cyhoeddwyd: (2003)
• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma
  gan: Croucher, P, et al.
  Cyhoeddwyd: (2001)
• Bone marrow endothelial cells produce osteoprotegerin: Evidence for a role in the development of myeloma bone disease
  gan: De Leenheer, E, et al.
  Cyhoeddwyd: (2004)
• Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
  gan: Croucher, P, et al.
  Cyhoeddwyd: (2001)
• Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma.
  gan: Croucher, P, et al.
  Cyhoeddwyd: (2000)